MedTrace Logo

Performance Assessement for Paralympic Athletes

NCT04748497 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 134

Last updated 2022-03-22

No results posted yet for this study

Summary

The primary objective of the study: improvement of sportive performances by quantification and performances monitoring of paralympic athletes.

The secondary objectives of the study:

* quantification and performances monitoring of mechanical performances during the filed tests, the laboratory analysis and the sportive competitions;
* quantification and performances monitoring of physiological performances during the filed tests, the laboratory analysis and the sportive competitions;
* quantification and risk monitoring of discipline-relative musculo-squeletic troubles, caused by training or using of sportive equipment;
* quantification and mechanical monitoring by the made-to-measure or usual sportive material.

Conditions

  • Paralympic Athletes
  • Sportive Performance

Interventions

OTHER

Standardization of evaluation and follow-up

Standardization of evaluation and clinical and sportive follow-up of athletes. Made-to-measure technical supports will be tested regarding the Paralympic regulations.

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • François Genêt, MD, PhD · Service Médecine Physique et de Réadaptation, Hôpital Raymond Poincaré, APHP

  • Jean François Toussaint, MD, PhD · Centre d'Investigation en Médecine du Sport, Hôpital Hôtel Dieu, APHP

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-08
Primary Completion
2024-06-30
Completion
2024-06-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04748497 on ClinicalTrials.gov